Xenon Pharmaceuticals, Inc. (XENE)
54.39
-1.61
(-2.88%)
USD |
NASDAQ |
May 15, 16:00
52.65
-1.74
(-3.20%)
After-Hours: 20:00
Xenon Pharmaceuticals Shareholders Equity (Quarterly) : 1.338B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 567.63M |
| Alkermes Plc | 1.752B |
| Edesa Biotech, Inc. | 10.20M |
| ProMIS Neurosciences, Inc. | 60.72M |
| Tyra Biosciences, Inc. | 387.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.387B |
| Total Liabilities (Quarterly) | 48.99M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 27.79 |
| Net Debt Paydown Yield | 0.01% |